Piper Sandler analyst Adam Maeder maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report) today and set a ...

Axonics, Inc. AXNX recently achieved a milestone with the CE Mark approval of its fourth-generation rechargeable Sacral Neuromodulation (SNM) system, the R20. This groundbreaking device is set to ...

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a unanimous verdict in a patent infringement lawsuit brought by larger rival ...

AXNX) on Thursday reported second-quarter net income of $6.9 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Irvine, California-based company said it ...

Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the ...

Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

IRVINE, Calif., August 01, 2024--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder ...